Clinical Trial Update: A Phase 2 Clinical Study of ABSK061 and ABSK043 [Phase 2]

View source ↗

Summary

Abbisko Therapeutics is recruiting for a Phase 2 study of ABSK061 and ABSK043 in multiple cancers, including HER2-positive gastric/gastroesophageal junction can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer
• Non-small Cell Lung Cancer
• Solid Tumors
• Urothelial Carcinoma

Drugs mentioned

• ABSK043 (ABSK043)
• ABSK061

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma | Phase 2 | Status: RECRUITING